1st Annual Cardiac Safety Conference
Venue: Maritim Pro Arte Hotel
Event Date/Time: Dec 04, 2006 | End Date/Time: Dec 05, 2006 |
Description
In addition, recent concerns involving certain COX-2 specific NSAID have highlighted the need for broader cardiac safety surveillance and Cardiac Risk Management (CRM) programmes, extending well beyond regulatory approval into the marketing stage. These concerns have now triggered further regulatory reviews of the drug development process and are expected to introduce further changes to the drug approval process and the post marketing commitments of drug manufacturers.
This programme will review and address the above cardiac safety topics and will bring industry, academic and regulatory experts and representatives together with the aim of exchange of ideas and sharing information with the audience.